Overview

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

Status:
Completed

Trial end date:
2016-09-08

Target enrollment:

Participant gender:

Summary

The purpose of this study was to examine how well the combination of two medicines (solifenacin succinate and mirabegron) worked compared to each medicine alone in the treatment of bladder problems, and how safe they were for long term use.

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Europe B.V.

Treatments:

Mirabegron
Solifenacin Succinate